Allworth Financial LP Summit Therapeutics Inc. Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Allworth Financial LP holds 1,022 shares of SMMT stock, worth $21,349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,022
Previous 22
4545.45%
Holding current value
$21,349
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
150Shares Held
66.3MCall Options Held
1.05MPut Options Held
1.07M-
Baker Bros. Advisors LP New York, NY23.2MShares$485 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$86.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$61.9 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.2B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...